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Background: Little is known of the epidemiology of primary headache disorders in sub-Saharan Africa. We
performed a population-based survey in Zambia using methods previously tested in multiple other countries.
Methods: This cross-sectional survey was conducted by visiting households unannounced, using cluster-randomized
sampling, in the mostly urban Lusaka Province and mostly rural Southern Province. Within clusters, households were
selected randomly, as was one adult member (18-65 years old) of each selected household. A structured questionnaire,
translated into the local languages, was administered face-to-face by trained interviewers. Demographic enquiry was
followed by diagnostic questions based on ICHD-II criteria. A random sub-sample of
participants were invited for subsequent physician-interview to validate the diagnostic part of the questionnaire.
Results: Of 1,134 eligible household members contacted, 1,085 (450 male, 887 urban) consented to interview
(refusal rate 4.3%). Others who had been selected but remained unavailable on three visits were not counted as
refusals since their reasons were unknown, but gave rise to gender biases, being mostly male in urban areas and
mostly female in rural areas. Statistical correction was applied. Adjusted for gender and habitation (urban/rural),
the 1-year prevalence of any headache was 61.6%, of migraine 22.9%, of tension-type headache (TTH) 22.8%, of
headache on ≥15 days/month 11.5% and of probable medication-overuse headache (pMOH) 7.1%. The adjusted
point-prevalence of any headache (headache yesterday) was 19.1%. There was a small proportion (5.3%) of
unclassified headache, some of which may have been secondary. The overwhelmingly strong association was
between urban dwelling and pMOH (OR: 8.6; P=0.0001), with an urban prevalence of 14.5% (gender-adjusted).
Validation of the questionnaire was limited by participants’ reluctance to present for physician review, substantial
delays in doing so and major self-selection bias among those who did. These were unavoidable problems in
resource-limited Zambia.
Conclusions: Primary headache disorders, common in high-income countries, are at least as prevalent in Zambia,
a sub-Saharan African country. The selectively urban problem of pMOH seems likely to reflect ready availability
of non-prescription analgesics, without easy access to professional health care for headache or any focused
public-health education regarding correct usage of analgesics or the dangers of their overuse.
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Worldwide, headache disorders are among the most
common medical conditions. According to the Global
Burden of Disease Study 2010 (GBD 2010), tension-type
headache (TTH) and migraine are respectively the second
and third most prevalent diseases globally (behind dental
caries) [1,2]. Migraine is the seventh leading specific cause
of years of life lost to disability (YLDs), responsible for
2.9% of all YLDs, and more than half of all YLDs attribut-
able to neurological disorders [1-3]. Both migraine and
TTH can lead, through mistreatment, to medication-
overuse headache (MOH), which by definition occurs on
≥15 days/month and is a major contributor to disability
burden at the individual level [4].
GBD 2010 relied upon epidemiological evidence from
all regions of the world. There were, however, consider-
able gaps in this knowledge; this was true for all world
regions, but particularly so in several [5]. In sub-Saharan
Africa (SSA), as a case in point, there had been few stud-
ies of prevalence of primary headache disorders, most of
these had been in select sub-populations and none had
assessed burden [6-14]. Prevalence estimates, perhaps
not surprisingly, had varied considerably: in Zimbabwe,
Quesada-Vazquez et al. reported a primary headache
disorder in 37.1% of psychiatric hospital workers [7]; in
rural Ethiopia, Takele et al. recorded headache in 16.4%
of mill workers [8]; in a rural community of Benin,
Houinato et al. estimated a 3.3% lifetime prevalence of
migraine [11]; and in northern Tanzania Winkler et al.
reported a 7.0% 1-year prevalence of TTH and 4.3% of
migraine [10,12]. This range of variation undoubtedly
reflected differences in methodology and, especially, case
definition, as well as in the selected populations sur-
veyed [15]. These estimates were, nonetheless, consistent
in one respect: all were considerably lower than global
averages [5].
The aim of this study, a project within the Global
Campaign against Headache [16-19], was to fill the
knowledge gap regarding primary headache disorders
in the general population of Zambia. It was the first
such study in the African Region, and undertaken pri-
marily to inform health policy-makers. Understanding
the scale and scope of the burden of headache dis-
orders is the basis of health-needs assessment, of
planning effective health services and of appropriate
resource-allocation for what is and should be seen as
a public-health priority [20]. We estimated 1-year
prevalence of headache, migraine, TTH, all causes of
headache on ≥15 days/month, MOH (as probable MOH
[pMOH]) and point (1-day) prevalence of headache
(“headache yesterday”); these are reported here. We also
assessed disability and other aspects of burden attrib-
utable to these disorders, which will be described
elsewhere.Methods
Ethics
This study was approved by the University of Zambia’s
Research Ethics Committee. Verbal informed consent was
obtained from key informants and all participants before
we asked the survey questions.
Study design
This was a cross-sectional questionnaire survey of adults
aged 18–65 years, conducted door-to-door. Participants
were randomly selected from two of the nine provinces
of Zambia: the mostly urban population in Lusaka Prov-
ince, and the mostly rural population in the Southern
Province.
Instrument
We used a local culturally-adapted version of the struc-
tured questionnaire [21] developed for these surveys by
Lifting The Burden (LTB) [16-19] and employed previ-
ously in Russia [22], China [23] and India [24] and sub-
sequently in a total of 19 countries in 18 languages [21].
The questionnaire was translated according to LTB’s
translation protocol for lay documents [25] from English
into three local languages: Bemba and Nyanja for Lusaka
Province, and Tonga for the Southern Province.
The questionnaire was composed of five parts: personal
and demographic enquiry, and headache screening ques-
tions, which were addressed to all respondents; these were
followed in those screening positively by diagnostic
questions, enquiry into burden and questions on selected
comorbidities.
The screening question for headache was: “In the last
year, have you had headache that was not part of
another illness?” Participants who answered “no” were
classified as headache-free; those who answered “yes”
were asked if all their headaches were of one or more
types and, if more than one, to focus in the subsequent
questions on the one that was most bothersome. Only
that headache was diagnosed. The point prevalence of
headache was estimated by asking: “Did you have a
headache yesterday?”
Selection and training of interviewers
In Lusaka Province, interviewers were interested faculty
and advanced students from Chainama College of Health
Sciences. In the Southern Province, interviews were con-
ducted by the Chikankata Epilepsy Care team, whose staff
had been conducting community- and hospital-based re-
search for over a decade.
All interviewers attended a 3-day training session at
Chainama Hills College Hospital, Lusaka. Training inclu-
ded clinical aspects of headache disorders and the theoret-
ical and practical aspects of the study design and purpose
Mbewe et al. The Journal of Headache and Pain  (2015) 16:30 Page 3 of 9and application of the questionnaire. The interviewers
were then assessed in supervised interviews.
Pre-pilot and pilot surveys
A clinic-based, pre-pilot study was conducted in two
urban health centres in Lusaka. The original English-
language version of the draft questionnaire was adminis-
tered by physicians, clinical officers or nurses, translated
at point of application, to 20 adults aged 18–65 years in
an approximately equal mix of patients presenting with
headache and others with unrelated disorders. The pur-
pose was to establish that questions were acceptable and
inoffensive. This exercise guided local cultural adapta-
tion of the questionnaires, and led to a final draft.
The pilot survey was community-based, conducted in
both rural and urban areas using the translated final-
draft questionnaires over the course of two months.
Convenient communities were identified in the two
provinces, and 10 adults aged 18–65 years were selected
from each by a mixture of convenience and purposive
sampling. Thus a total of 20 adults were interviewed by
physicians, clinical officers or nurses. The purpose was
to test the translated questionnaires, in the field, for
feasibility. Final adaptations were made based upon feed-
back from this exercise.
Sampling, and main survey
The main study used cluster-sampling followed by simple
random sampling of dwellings and of one adult participant
within each household’s family.
Sampling was facilitated by previously-collected census
data providing neighbourhood blocks and household
locations. In each urban or rural area, the interviewers
randomly selected blocks or circumscribed collections of
dwellings (clusters), and then one or more dwellings
within each of these. When the door to a selected dwell-
ing was not answered at first visit, two further visits
were made on subsequent days before the dwelling was
excluded and replaced by another in the block.
Within selected dwellings, each non-biologically related
family was a sampling unit. A key informant was asked to
list all members aged 18–65 years within the family. This
informant was preferably the female head-of-household,
who traditionally takes responsibility for and is most
knowledgeable of other household members’ health. The
Kish grid method [26] was applied to select one member
from this list for interview. When that person was present,
he or she was asked the demographic and screening ques-
tions; when not, the female head-of-household would an-
swer them on that person’s behalf. When the screening
question was answered positively (ie, headache was repor-
ted in the last year), and the person was present, the full
interview was conducted immediately; otherwise, an ap-
pointment was made for a return visit when the personwas expected to be at home. Any selected respondent who
remained unavailable after three visits was replaced from
another household.
Data collection in the field was quality-assured by EM,
who made random unannounced checks of interviewers’
work in the field.
Validation
A sub-sample of 50 participants from each province were
randomly selected for validation of the diagnostic ques-
tionnaire. With only two full-time adult neurologists to
serve all the clinical, administrative and educational needs
of this country of >13 million people, specialist-level
evaluation for the validation study was not possible. Two
physicians, a general medical officer in the rural region
(PZ) and a psychiatrist in the urban (RP), received add-
itional training from a neurologist (GB) in headache diag-
nosis according to ICHD-II [27]. They were blinded to the
participants’ questionnaire responses, and used their
clinical judgement as well as ICHD-II criteria to make
diagnoses deemed to be the gold standard. The goal was
to complete these evaluations within 1 month of the par-
ticipants’ completion of the questionnaire.
Data management
Completed paper questionnaires and physicians’ evalua-
tions were transported to the central research office for
data entry into Microsoft Excel and eventual importation
into SAS. A 20% random check of records was undertaken
to assure data-entry quality with an error rate of <2%
identified. Paper records were stored securely for quality
checks and data confirmation.
Analysis and statistics
Age in years was analyzed as a categorical variable (18–29,
30–39, 40–49, 50–65). Marital status was classified as
single, married, widowed or divorced. Educational level
was classified as primary (grades 1–7), secondary (grades
8–12) or higher education (college or university). Employ-
ment status was categorized as unemployed, or as un-
skilled, skilled or professional work. Income per capita per
month was categorized as below or above the poverty line
(~ USD 40; at the time of the survey, USD 1 = ZMK
5,173) [28].
Interviewers did not make diagnoses. These were
derived during analysis, algorithmically [21], from the
questionnaire responses. Participants reporting headache
on ≥15 days/month were first separated and described
as a separate group because they cannot be adequately
diagnosed by questionnaire [21]. However, those with
headache on ≥15 days/month who also reported regular
use of headache medication on >3 days/week were consid-
ered to have pMOH. To all others, the algorithm applied
ICHD-II criteria in the order: migraine, TTH, probable
Table 1 Demographic characteristics of the study sample
All
n (%)
Rural
n (%)
Urban
n (%)
P-valuea
Total 1,085 (100.0) 198 (100.0) 887 (100.0)
Gender <0.0001
Female 635 (58.5) 75 (37.9) 560 (63.1)
Male 450 (41.5) 123 (62.1) 327 (36.9)
Age (years) 0.0004
18-29 370 (34.1) 93 (47.0) 277 (31.2)
30-39 361 (33.3) 51 (25.8) 310 (35.0)
40-49 207 (19.1) 33 (16.7) 174 (19.6)
50-65 147 (13.5) 21 (10.6) 126 (14.2)
Marital status <0.0001
Single 310 (28.6) 72 (36.4) 238 (26.8)
Married 549 (50.6) 108 (54.6) 441 (49.7)
Widowed 114 (10.5) 13 (6.6) 101 (11.4)
Divorced 110 (10.1) 5 (2.5) 105 (11.8)
Educational level <0.0001
None/primary 270 (24.9) 71 (35.9) 199 (22.4)
Secondary 584 (53.8) 78 (39.4) 506 (57.1)
Higher 225 (20.7) 49 (24.8) 176 (19.8)
Employment <0.0001
Unemployed 476 (43.9) 117 (59.1) 359 (40.5)
Unskilled 282 (26.0) 51 (25.8) 231 (26.0)
Skilled 174 (16.0) 19 (9.6) 155 (17.5)
Professional 137 (12.6) 11 (5.6) 126 (14.2)
Income per month <0.0001
≤ USD 40 258 (23.8) 121 (61.1) 137 (15.5)
> USD 40 827 (76.2) 77 (38.9) 750 (84.6)
aP-values (Chi-squared) compared distributions within the variable between
rural and urban participants.
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able migraine, and of TTH and probable TTH, were then
combined for prevalence estimation and further analyses
[15]. Remaining cases were unclassified.
We recorded headache frequency in days over the pre-
ceding 3 months, and typical headache intensity on a
verbal rating scale (“not bad”, “quite bad” and “very bad”).
The latter ratings were transformed into a numerical scale
1–3, which was treated as a continuous variable.
For the validation exercise comparing questionnaire-
derived and physicians’ diagnoses, sensitivity, specificity
and positive (PPV) and negative predictive values (NPV)
were calculated with 95% confidence intervals (CIs). We
used Cohen’s kappa coefficient to estimate overall agree-
ment between diagnoses.
Analyses were performed with SAS version 9.2 (SAS
Institute Inc, Cary, NC, USA) or Excel 2007 (Microsoft
Corporation, Redmond, WA, USA). We calculated P-
values as an aid to interpretation. Chi-squared, Fisher’s
exact and binomial proportion tests were applied to
compare distributions and proportions. We used logistic
regression analysis to examine associations between de-
mographic variables and prevalence, calculating odds
ratios (ORs) and adjusted ORs with 95% CIs.
Results
Of 1,134 household members contacted in the main sur-
vey, 1,085 (450 male, 635 female; 198 rural [Southern
Province], 887 urban [Lusaka Province]) consented to be
interviewed (refusal rate 4.3%). They were selected from
3,035 enumerated eligible adults (1,448 male, 1,587
female) in these households. The sociodemographic char-
acteristics of participants are displayed in Table 1. The
male:female ratio of our sample (41.5:58.5) diverged from
the national ratio (very close to 50:50) [29]. The sample
also did not match the urban/rural distribution (40:60) of
the Zambian population [29]. Adjustments to observed
prevalences were therefore necessary for both gender and
habitation, and are reported below. Rural participants
were more often male, younger, less well educated, more
likely to be unemployed, less likely to be in skilled or
professional work and on lower incomes than urban
participants. However, marital status, education level,
employment status and income levels in our samples
were consistent with those of the Lusaka and Southern
Province populations [29].
Prevalence overall and by age, gender and habitation is
set out in Table 2. In total, 781 participants (72.0%; males
66.2%, females 76.1%) reported headache unrelated to an-
other illness in the past year, and 307 (28.3%; males 21.3%,
females 33.1%) reported headache on the day prior to the
interview (headache yesterday). Any headache in the last
year (75.7% vs 52.1%, gender-adjusted) and headache
yesterday (30.4% vs 11.5%, gender-adjusted) were bothmore prevalent among urban than rural dwellers. Ad-
justed for gender and habitation, the 1-year prevalence of
any headache was 61.6% and the point prevalence (head-
ache yesterday) was 19.1%. Point prevalence increased
consistently with age (Table 2), an association which ap-
peared to be driven by pMOH (see below).
The observed 1-year prevalence of migraine was 23.3%
(12.7% definite, 10.6% probable), with a female preponder-
ance of about 3:2 (Table 2) (gender- and habitation-
adjusted: 22.9%). The observed 1-year prevalence of TTH
was 24.2% (16.8% definite, 7.4% probable), with a male
preponderance of about 4:3 (gender- and habitation-
adjusted: 22.8%). Migraine prevalence peaked during the
ages 40–49 years, then dropped to its lowest level in those
aged 50–65 years. TTH was most common in those aged
30–39 and least common in those over 50. There was a
small proportion (5.3%) of unclassified episodic headache,
Table 2 Observed 1-year prevalence (% [95% confidence interval]) by gender, age and habitation, and by headache type
Migraine
(n = 253)
TTH
(n = 263)
Any headache on ≥15d/m
(n = 207)
pMOH
(n = 138)
Any headache yesterday
(n = 307)
All 23.3 [20.9-25.9] 24.2 [21.8-26.9] 19.1 [16.9-21.5] 12.7 [10.9-14.8] 28.3 [25.7-31.1]
Gender
Male 18.0 [14.7-21.8] 27.8 [23.8-32.1] 14.9 [11.9-18.5] 9.3 [7.0-12.4] 21.3 [17.8-25.3]
Female 27.1 [23.8-30.7] 21.7 [18.7-25.1] 22.1 [19.0-25.4] 15.1 [12.5-18.1] 33.1 [29.5-36.8]
Age (yr)
18-29 24.9 [20.7-29.5] 24.3 [20.2-29.0] 14.6 [11.3-18.6] 7.0 [4.8-10.1] 24.9 [20.7-29.5]
30-39 22.1 [18.1-26.7] 27.7 [23.3-32.5] 17.5 [13.9-21.7] 12.5 [9.4-16.3] 28.0 [23.6-32.8]
40-49 26.6 [21.0-33.0] 23.2 [17.9-29.4] 20.2 [15.4-26.3] 15.5 [11.1–21.1] 30.0 [24.1-36.5]
50-65 17.7 [12.3-24.7] 17.0 [11.7-26.5] 32.7 [25.6-40.6] 23.8 [17.6-31.3] 34.7 [27.5-42.7]
Habitation
Rural 21.7 [16.5-28.0] 22.7 [17.4-29.1] 4.0 [1.9-7.9] 2.0 [0.6-5.3] 11.6 [7.8-16.9]
Urban 23.7 [21.0-26.6] 24.6 [21.9-27.5] 22.4 [19.8-25.3] 15.1 [12.9-17.6] 32.1 [29.1-35.3]
TTH: tension-type headache; pMOH: probable medication-overuse headache; d/m: days/month.
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groups.
Headache on ≥15 days/month was reported by 207
participants (19.1%; male:female about 2:3) and diag-
nosed as pMOH in 12.7% (male:female about 3:5)
(Table 2). Prevalence of pMOH increased steadily with
age; prevalence of other headache on ≥15 days/month
fluctuated, but again was highest in those aged 50–65
years (Table 2). A far larger proportion of urban (22.4%)
than of rural participants (4.0%; P < 0.05 [binomial pro-
portional test]) had headache on ≥15 days/month, and a
very marked difference was observed in the prevalenceTable 3 Bivariate analysis of associations with each diagnosis
Migraine Tens
OR P OR
Habitation
Rural reference refere
Urban 1.1 [0.77-1.6] 1.1 [0
Education
None/primary reference refere
Secondary 1.4 [0.95-2.0] 0.46
College or university 2.1 [1.4-3.2] 0.0004 0.22
Employment
None reference refere
Unskilled 1.2 [0.84-1.7] 1.5 [1
Skilled 1.1 [0.83-1.6] 1.6 [1
Professional 2.1 [1.4-3.2] 0.0005 0.46
Income per month (USD)
≤40 reference refere
>40 1.3 [0.88-1.8] 1.3 [0
pMOH: probable medication-overuse headache; OR: odds ratio with 95% confidencof pMOH (urban 15.1% [gender-adjusted: 14.5%]; rural
2.0% [gender-adjusted: 2.1%]; P < 0.05). Bivariate analysis
confirmed the very strong association between pMOH
and urban dwelling (OR = 8.6 [95% CI 3.2-23.6]; P =
0.0001) (Table 3). The gender- and habitation-adjusted
prevalence of pMOH was 7.1% and of other headache on
≥15 days/month was 4.4%.
We also used bivariate analysis to examine associations
with socioeconomic indicators (Table 3). Increasing edu-
cational level was quite strongly associated with more
migraine and less TTH (ORs respectively of 2.1 and 0.22
for those attending college or university) but had noadjusted for gender and age
ion-type headache pMOH
P OR P
nce reference
.77-1.6] 8.6 [3.2-23.6] 0.0001
nce reference
[0.34-0.64] <0.0001 0.59 [0.38-0.90] 0.0147
[0.14-0.37] <0.0001 1.1 [0.71-1.8]
nce reference
.1-2.1] 0.0149 1.6 [1.1-2.6] 0.0232
.2-2.2] 0.0010 1.5 [1.03-2.3] 0.0343
[0.26-0.82] 0.0080 1.5 [0.91-2.7]
nce reference
.93-1.9] 6.0 [2.8-13.1] <0.0001
e interval in parenthesis.
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employment, with professionals showing ORs for mi-
graine and TTH of 2.1 and 0.46 compared with those
not employed. All employed groups were somewhat
more likely (OR ~ 1.5) to have pMOH. In bivariate ana-
lysis, higher income (above USD 40 per month) was
weakly and non-significantly associated with migraine
and TTH but strongly and significantly with pMOH
(OR = 6.0; P < 0.0001). Higher income was also strongly
associated with urban dwelling (P < 0.0001) (Table 1),
and the association between higher income and pMOH
did not survive multivariate analysis in the logistic regres-
sion model.
Headache frequency overall was high (mean 10.3 days/
month), creating among those with headache a probabil-
ity of headache on any particular day of 0.34. Headache
frequency averaged 3.4 days/month among people with
migraine and 2.5 days/month among those with TTH,
while participants diagnosed with pMOH had headache
virtually every day. Three quarters (74.2%) of partici-
pants with migraine and over two thirds (69.6%) with
pMOH, but only 13.3% with TTH, reported “very bad”
headaches. Since headache intensity ratings were trans-
formed into a numerical continuous variable from 1
(“not bad”) to 3 (“very bad”), the means were 2.7 for mi-
graine, 2.6 for pMOH, and 1.9 (implying moderate inten-
sity) for TTH.
Validation
Household occupants were generally willing to partici-
pate in the main survey, conducted at home. However,
physician-evaluation for the validation exercise required
travel to a local health-care facility, and there was signifi-
cant reluctance among invited participants, especially
within the urban population, to make this effort. More
than half declined outright; others agreed but did not
appear for their appointments. Among those who arrived,
>90% presented >1 month after their initial interview,
some as late as 4 months. Many came with complaints of
recent worsening in headache frequency and/or severity,
and were primarily motivated to seek health-care services.
An inevitable consequence was that the validation sub-
sample were, through self-selection, considerably at oddsTable 4 Comparison of questionnaire diagnoses in survey sam
Survey sample (n = 1,085)
No headache (%) 304 (28.0)
Unclassified headache (%) 58 (5.3)
Migraine (%) 253 (23.3)
TTH (%) 263 (24.2)
pMOH (%) 138 (12.7)
TTH: tension-type headache; pMOH: probable medication-overuse headache.
aP-values (Fisher’s exact test) compared the difference in proportions with the diagndiagnostically (by questionnaire) with the overall sample
(Table 4).
Within the participants from the validation sub-sample
who were actually reassessed, the questionnaire appeared
more sensitive in diagnosing migraine (sensitivity: 48.0%)
and more specific for TTH (specificity: 81.0%). However,
the kappa coefficients demonstrated poor agreement be-
tween physicians’ and questionnaire diagnoses (Table 5).
Discussion
This study was the first population-based survey to esti-
mate the prevalence of primary headache disorders in
Zambia, and one of the first in SSA. It employed estab-
lished methods [15] and questionnaire [21-24]; it included
diverse regions, employed an appropriate mix of cluster-
sampling and simple random sampling, and applied
ICHD-II diagnostic criteria [27]. These were considerable
strengths.
Yet studies of this nature are challenging in a country
like Zambia, with insufficiencies in health-care infra-
structure and personnel. We intended to recruit a larger
sample, based on expectations of lower prevalences of all
headache types [6-14], but in fact achieved an adequate
overall sample size (>1,000) in view of the prevalences ac-
tually observed. We did not, however, balance the sample
well between urban and rural areas. Surveying the latter
was far more demanding of resources (human more than
financial), and our interviewers found it difficult against
competing demands to spend the necessary time travel-
ling. This imbalance was a significant study limitation,
even though statistical correction could be applied.
We also did not achieve a good gender balance despite
random sampling at household level and a very low refusal
rate (4.3%) among household members actually contacted.
There was a slight overall female preponderance of 52.3%
among the 3,035 enumerated eligible adults, but an add-
itional explanation must be found. Potential respondents
selected for interview who remained unavailable on three
visits were replaced from other households; they were not
counted as refusals since their reasons for being unavail-
able were unknown. Unfortunately the interviewers failed
to keep records of these people, but those away from the
home were mostly male in urban areas and mostly femaleple and validation sub-sample
Validation sub-sample (n = 99) P-valuea
0 (0.0) <0.0001
10 (10.1) 0.0670
45 (45.5) <0.0001
22 (22.2) 0.7137
22 (22.2) 0.0131
osis between survey and validation samples.
Table 5 Diagnostic validation exercise (findings derived
from comparisons between questionnaire-diagnoses and
physician-diagnoses made up to four months later in
self-selecting participants from the validation sub-sample)
(see text)
Migraine TTH
Sensitivity* 48.0 [34.2-61.9] 27.8 [13.2-42.4]
Specificity* 57.1 [43.3-71.0] 81.0 [71.3-90.7]
PPV* 53.3 [38.8-67.9] 45.5 [24.7-66.3]
NPV* 51.9 [38.5-65.2] 66.2 [55.7-76.8]
Kappa 5.14% 9.52%
*Values are shown with 95% confidence intervals in parentheses.
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biases arose. Again, statistical correction could be applied,
but the concern here is that failure of certain respondents
to be available might reflect (lack of) interest-bias. In fact,
the opposite could be the case: the screening question was
commonly answered by the female head-of-household
and, when negative, absence of the participant was not an
issue. In other words, a selected respondent without head-
ache had a somewhat higher probability of being included
in the survey than one with headache.
Among the countries where the methodology had pre-
viously been employed were India [30] and Pakistan
[31], which have many similar problems. Unlike these
two countries, Zambia has an almost total lack of neu-
rologists, which made application of a “gold standard”
very difficult for the purpose of the diagnostic validation
exercise. Additionally, physicians are too few in Zambia
to justify, ethically or logistically, sending them into the
communities to conduct validation assessments. As a
consequence, people in the validation sub-sample who
undertook the travel to a local health-care facility were
highly self-selecting (45.5% migraine, 22.2% pMOH), and
this factor undoubtedly explained the high proportion
with more troublesome headache, likely also to be diag-
nostically difficult. More problematic than this, there
were unwanted delays of months between survey and
physician evaluations, allowing the possibility of real
change in the headache disorder. Community health
workers were asked why participants were so reluctant
to take advantage of the opportunity for free physician
evaluation. Inconvenience and travel distances were
cited, but the key issue was the stigma attached to seeking
services at health-care facilities associated with psychiatric
illness. The structure of health-care services in Zambia
mirrors the World Health Organization organizational
model: health-care personnel and institutions responsible
for neurological care (and therefore for performing the val-
idation examinations) were also those providing mental-
health services. The stigma of mental illness in Africa
has been well described [32,33]. Ultimately, the validationexercise was unreliable, rather than the diagnostic ques-
tionnaire. It was disappointing that we could not prove its
validity in the three local languages, but the questionnaire
already had a record of successful use in many countries
and cultures [21-24].
The reported 1-year prevalence of all headache was
72.0% (gender- and habitation-adjusted 61.6%), of mi-
graine 23.3% (22.9%), of TTH 24.2% (22.8%), of headache
on ≥15 days/month 19.1% (11.5%) and of pMOH 12.7%
(7.1%). Globally, 47% of adults have been estimated to
experience headache at least once within a year [5], with
the most recent prevalence estimates coming from GBD
2010 for migraine (14.7%) and TTH (20.1%) [2]. No reli-
able global estimate is yet available for pMOH, because so
few studies have been conducted and case-ascertainment
is difficult [34], but a recent review found that estimates
clustered around 1–1.5% [35] while all headache on
≥15 days/month may affect 3% of adults [36]. Compari-
sons with epidemiological studies elsewhere, using the
same methods and questionnaire, put the prevalence esti-
mate for migraine in Zambia towards the upper end of
the range of these studies (India 25.2% [unpublished],
Russia 20.8% [37], China 9.3% [38]) and within the range
for TTH (India 35.1% [unpublished], Russia 30.8% [37],
China 10.8% [38]). Therefore our Zambian data are in
contradiction of previous studies in SSA (surveying less
representative populations) which reported substantially
lower estimates for both migraine (3.3% in rural Benin
[11]) and TTH (7% in northern Tanzania [10]). Primary
headache is at least as common in Zambia as in the rest of
the world, which carries a very important public-health
message for this country and probably the entire region.
All types of headache were more common in urban
areas. For migraine and TTH the association between
headache and urbanicity was weak and insignificant, but
for headache on ≥15 days/month it was very strong
(Table 2). We noted earlier that rural participants were
less well educated and on lower incomes than urban
participants, which might be expected to increase the
prevalence of headache [39-42] and therefore show the
opposite effect. On the other hand, people in rural
Zambia are probably more physically active, with less ex-
posure to processed food and lower rates of obesity –
trends that are reversed in more developed countries,
where the poor are disproportionately exposed to phys-
ical inactivity, high-calorie low-nutrient diets, obesity
and diabetes [43-45]. This may be telling us something
about risk factors for headache, which perhaps will in-
crease as the world becomes ever-more urbanized.
The striking finding in this study, of course, was the
high prevalence of pMOH (gender- and habitation-
adjusted: 7.1%), which compares with the global range of
up to 7% but with most estimates within 1–1.5% [5,35].
While explanation is called for, clinical studies rather
Mbewe et al. The Journal of Headache and Pain  (2015) 16:30 Page 8 of 9than epidemiological are needed to provide it. Mean-
while we can suggest the following as likely: the limited
access to health care, and the limited expertise in manage-
ment of headache disorders among the few health-care
workers who are available, lead to a culture of re-
course to analgesics obtained over-the-counter, which is
unrestrained by any public health-education. Escalating
use follows, this being the behaviour typically leading to
MOH everywhere. There is convincing support for this
from the urban/rural difference: while the prevalence of
pMOH in rural areas (2.1% gender-adjusted) is high but
not especially so in global terms [35], it is totally eclipsed
by the egregious, and alarming, urban prevalence of 14.5%
(gender-adjusted). We would expect an urban/rural differ-
ence: the very limited access to over-the-counter medica-
tion prevents such recourse to it in rural areas.
The high prevalence of pMOH largely drove the not-
ably high mean headache frequency overall (10.3 days/
month, whereas both migraine and TTH occurred, on
average, on <1 day/week). This created a probability of
headache on any particular day among those with head-
ache of 0.34, and a predicted 1-day prevalence of 24.5%
(0.34*72%). The reported prevalence of headache yester-
day was a very compatible 28.3%, which shows two things:
it affirms the veracity of these findings, especially with
regard to the high-frequency headache, and it demon-
strates the worth of epidemiological enquiry into headache
yesterday.
The proportion of unclassified headache was not un-
duly high (5.3%), but we will say something about it. It
was quite constant across both genders and all ages.
Diagnoses were made algorithmically, applying, in order,
ICHD-II criteria for migraine, TTH, probable migraine
and probable TTH [15,27], having first separated partici-
pants with headache on ≥15 days/month. These 5.3% of
participants therefore described headache on <15 days/
month meeting none of these criteria. The questionnaire
was not designed to capture secondary headache disor-
ders, and, although the screening question (“In the last
year, have you had headache that was not part of an-
other illness?”) endeavoured to exclude these, it might
not have succeeded if the underlying illness had not
been diagnosed, or causation recognised. In Zambia, an
obvious possibility was headache attributed to malaria.
We should add that the last part of this screening question
is not now recommended, because respondents might
wrongly attribute headache to another illness and be
inappropriately excluded without further enquiry [15].
The high prevalence of reported headache suggests this
did not happen often, if at all.
Conclusions
Primary headache disorders are no less common in
Zambia than in the rest of the world, where they are inthe top 10 causes of disability. Health policy-makers need
to be aware of this. There is a major problem of headache
on ≥15 days/month, largely consisting of pMOH; the lat-
ter, in theory, is entirely avoidable, and the urban/rural
divide supports this. Public education regarding the risk of
MOH is needed, and could be provided at relatively low
cost [46]. Other countries in SSA are likely to have similar
burdens of headache-related ill health.
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